Filing Details

Accession Number:
0000899243-20-019899
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-21 19:51:41
Reporting Period:
2020-07-21
Accepted Time:
2020-07-21 19:51:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1807901 Pandion Therapeutics Inc. PAND () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1679211 Polaris Partners Viii, L.p. One Marina Park Drive, 10Th Floor
Boston MA 02210
No No Yes No
1693818 Polaris Entrepreneurs' Fund Viii, L.p. One Marina Park Drive, 10Th Floor
Boston 02210
No No Yes No
1818137 Polaris Partners Gp Viii, L.l.c. One Marina Park Drive, 10Th Floor
Boston MA 02210
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-21 2,783,892 $0.00 2,783,892 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-07-21 272,046 $0.00 3,055,938 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-07-21 99,637 $0.00 99,637 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-07-21 9,736 $0.00 109,373 No 4 C Indirect See footnote
Common Stock Acquisiton 2020-07-21 34,863 $18.00 3,090,801 No 4 P Indirect See footnote
Common Stock Acquisiton 2020-07-21 1,248 $18.00 110,621 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2020-07-21 14,196,152 $0.00 2,783,892 $0.00
Common Stock Series A Preferred Stock Disposition 2020-07-21 508,090 $0.00 99,637 $0.00
Common Stock Series B Preferred Stock Disposition 2020-07-21 1,387,268 $0.00 272,046 $0.00
Common Stock Series B Preferred Stock Disposition 2020-07-21 49,652 $0.00 9,736 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The Series A Preferred Stock and Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and Series B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  2. The reportable securities are owned directly by Polaris Partners VIII, L.P. ("PP VIII"). Polaris Partners GP VIII, L.L.C. ("PPGP VIII") is the general partner of PP VIII. Each of David Barrett, Brian Chee, Amir Nashat and Bryce Youngren are the managing members of PPGP VIII (collectively, the "Managing Members"). Each of the Managing Members may be deemed to have shared voting and dispositive power over the shares held by PP VIII. Each of PPGP VIII and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  3. The reportable securities are owned directly by Polaris Entrepreneurs' Fund VIII, L.P. ("PEF VIII"). PPGP VIII is the general partner of PEF VIII. Each of the Managing Members may be deemed to have shared voting and dispositive power over the shares held by PEF VIII. Each of PPGP VIII and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.